|
positive regulation of endocytosis
|
GO_0045807 |
[Any process that activates or increases the frequency, rate or extent of endocytosis.] |
|
negative regulation of heart contraction
|
GO_0045822 |
[Any process that stops, prevents, or reduces the frequency, rate or extent of heart contraction.] |
|
negative regulation of blood circulation
|
GO_1903523 |
[Any process that stops, prevents or reduces the frequency, rate or extent of blood circulation.] |
|
positive regulation of heart contraction
|
GO_0045823 |
[Any process that activates or increases the frequency, rate or extent of heart contraction.] |
|
positive regulation of blood circulation
|
GO_1903524 |
[Any process that activates or increases the frequency, rate or extent of blood circulation.] |
|
negative regulation of isoprenoid metabolic process
|
GO_0045827 |
[Any process that stops, prevents, or reduces the frequency, rate or extent of the chemical reactions and pathways involving isoprenoid.] |
|
positive regulation of isoprenoid metabolic process
|
GO_0045828 |
[Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways involving isoprenoid.] |
|
negative regulation of isotype switching
|
GO_0045829 |
[Any process that stops, prevents, or reduces the frequency, rate or extent of isotype switching.] |
|
regulation of isotype switching
|
GO_0045191 |
[Any process that modulates the frequency, rate or extent of isotype switching.] |
|
negative regulation of B cell activation
|
GO_0050869 |
[Any process that stops, prevents, or reduces the frequency, rate or extent of B cell activation.] |
|
positive regulation of glycogen catabolic process
|
GO_0045819 |
[Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the breakdown of glycogen.] |
|
positive regulation of glycogen metabolic process
|
GO_0070875 |
[Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways involving glycogen.] |
|
regulation of glycogen catabolic process
|
GO_0005981 |
[Any process that modulates the frequency, rate or extent of the chemical reactions and pathways resulting in the breakdown of glycogen.] |
|
negative regulation of glycogen catabolic process
|
GO_0045818 |
[Any process that stops, prevents, or reduces the frequency, rate or extent of the chemical reactions and pathways resulting in the breakdown of glycogen.] |
|
negative regulation of glycogen metabolic process
|
GO_0070874 |
[Any process that stops, prevents, or reduces the frequency, rate or extent of the chemical reactions and pathways involving glycogen.] |
|
SNARE complex
|
GO_0031201 |
[A protein complex involved in membrane fusion; a stable ternary complex consisting of a four-helix bundle, usually formed from one R-SNARE and three Q-SNAREs with an ionic layer sandwiched between hydrophobic layers. One well-characterized example is the neuronal SNARE complex formed of synaptobrevin 2, syntaxin 1a, and SNAP-25.] |
|
Morgagni diaphragmatic hernia
|
HP_0025194 |
[An anterior retrosternal or parasternal hernia that can result in the herniation of liver or intestines into the chest cavity.] |
|
Central diaphragmatic hernia
|
HP_0025195 |
[A congenital diaphragm defect involving the central tendinous (e.g., amuscular) portion of the diaphragm, whereby the entire rim of diaphragmatic musculature is present.] |
|
Subtentorial periventricular white matter hyperdensity
|
HP_0025192 |
[Areas of brighter than expected signal on magnetic resonance imaging emanating from the cerebral white matter that surrounds the fourth cerebral ventricle (which is located beneath the tentorium of the cerebellum).] |
|
Posterolateral diaphragmatic hernia
|
HP_0025193 |
[A posterolateral defect in the diaphragm, commonly referred to as a Bochdalek hernia, which is often accompanied by herniation of the stomach, intestines, liver, and/or spleen into the chest cavity.] |